Lv1
20 积分 2025-09-11 加入
A novel anti-HER2/EGFR bispecific antibody–drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
1个月前
已完结
A Secreted Form of ADAM9 Promotes Carcinoma Invasion through Tumor-Stromal Interactions
1个月前
已完结
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
1个月前
已完结
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
1个月前
已完结
A novel pathway of human T lymphocyte activation. Identification by a monoclonal antibody generated against a rheumatoid synovial T cell line
1个月前
已完结
Preclinical development of MGC028, an ADAM9-targeted, glycan-linked, exatecan-based antibody-drug conjugate for the treatment of solid cancers
1个月前
已完结
Protective effects of C5a blockade in sepsis
2个月前
已完结
Anti-complement Strategies in Experimental Sepsis
2个月前
已完结
Protective effects of anti‐C5a peptide antibodies in experimental sepsis
2个月前
已完结
The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
2个月前
已完结
皖公网安备34019202002308
